Colombia vs Egypt: The number of people with susceptibility test result for rifampicin
Colombia
3,134
in 2021
Egypt
2,962
in 2021
Colombia rank
39th
Egypt rank
41st
The number of people with susceptibility test result for rifampicin over time
- Colombia
- Egypt
How they compare
Colombia currently reports 3,134 against 2,962 in Egypt, a difference of 172.
That makes Colombia's figure about 1.1 times Egypt's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Colombia ahead.
Colombia ranks 39th and Egypt ranks 41st of 155 countries.
Egypt has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Colombia | Egypt | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,906 | 2,475 | 569.33 | Egypt |
| 2020s | 2,255 | 2,888 | 633.5 | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Colombia or Egypt?
- Colombia, at 3,134 against 2,962 in Egypt as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Colombia and Egypt?
- 172, with Colombia ahead.
- How many years of comparable data are there for Colombia and Egypt?
- 5 years are reported by both, from 2017 to 2021.
- How do Colombia and Egypt rank globally for the number of people with susceptibility test result for rifampicin?
- Colombia ranks 39th and Egypt ranks 41st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.